Antimalarial Drug Resistance: Surveillance and Molecular Methods for National Malaria Control Programmes

Memorias do Instituto Oswaldo Cruz

Volumn 93, Issue 5, 1998, Pages 627-630

  D'Alessandro, Umberto ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Antimalarial drug resistance; In vitro test; In vivo test; Polymerase chain reaction; Surveillance

Indexed keywords

ANTIMALARIAL AGENT;

ANIMAL; ARTICLE; DRUG EFFECT; DRUG RESISTANCE; GENE; GENETICS; HEALTH SURVEY; HUMAN; MALARIA; PLASMODIUM; PUBLIC HEALTH;

ANIMALS; ANTIMALARIALS; DRUG RESISTANCE; GENES, PROTOZOAN; HUMANS; MALARIA; NATIONAL HEALTH PROGRAMS; PLASMODIUM; POPULATION SURVEILLANCE;

EID: 0032151591     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761998000500012     Document Type: Article

References (25)

1. Al-Yaman F, Genton B, Reeder JC, Anders RF, Alpers MP 1997. Evidence that recurrent Plasmodium falciparum infection is caused by recrudescence of resistant parasites. Am J Trop Med Hyg 56: 436-439.
2. Babiker H, Randford-Cartwright L, Sultan A, Satti G, Walliker D 1994. Genetic evidence that RI choloroquine resistance of Plasmodium falciparum is caused by recrudescence of resistant parasites. Trans R Soc Trop Med Hyg 88: 328-331.
3. Basco LK, de Pecoulas PE, Wilson CM, Le Bras J, Mazabraud A 1995. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum, Mol Biochem Parasitol 69: 135-138.
4. Baudon D 1995. La prise de décision dans la politique d'utilisation des antipaludiques en réponse à une modification de l'efficacité de la chloroquine. Réflexions appliquées à I'Afrique. Méd Trop 55: 37S-40S.
5. Bloland PB, Lackritz EM, Kazembe PN, Were JBO, Steketee R, Campbell CC 1993. Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. J Infect Dis 167: 932-937.
6. D'Alessandro U, Mutabingwa TK, Ouma JH, Watkins WM 1997. Report of the workshop on monitoring antimaiarial treatment efficacy: an East African regional network. Malaria Consortium, UK.
7. De Pecoulas PE, Basco LK, Le Bras J, Mazabraud A 1996. Association between antifol resistance in vitro and DHFR gene point mutation in Plasmodium falciparum isolates. Trans R Soc Trop Med Hyg 90: 181-182.
8. Draper CC, Hills M, Kilimali VAEB, Brubaker G 1988. Serial studies on the evolution of drug resistance in malaria in an area of East Africa: findings from 1979 up to 1986. J Trop Med Hyg 91: 265-273.
9. Foote SJ, Kyle DE, Martin RK, Oduola AM, Forsyth K, Kemp DJ, Cowman AF 1990. Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum. Nature 345: 255-258.
10. Jelinek T, Ronn AM, Curtis J, Duraisingh MT, Lemnge MM, Minha J, Bygbjerg IC, Warhurst DC 1997. High prevalence of mutations in the dihydrofolate reductase gene of Plasmodium falciparum in isolates from Tanzania without evidence of an association to clinical sulfadoxine/pyrimethamine resistance. Trop Med Intern Hlth 2: 1075-1079.
11. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellens TE 1995. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg 52: 565-568.
12. Plowe CV Djimde A, Wellems TE, Diop S, Kouriba B, Doumbo OK 1996. Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance. Am J Trop Med Hyg 55: 467-471.
13. Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, Estrada-Franco JG, Mollinedo RE, Avila JC, Cespedes JL, Carter D, Doumbo OK 1997. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiological patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis 176: 1590-1596.
14. Prasad RN, Prasad H, Virk KJ, Sharma VP 1990. Application of a simplified in-vivo test system for determining chloroquine resistance in Plasmodium falciparum. Bulletin WHO 68: 755-758.
15. Reeder JC, Rieckmann KH, Genton B, Lorry K, Wines B, Cowman AF 1996. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea, Am J Trop Med Hyg 55: 209-213.
16. Robert V, Molez JF, Trape JF 1996. Short report: gametocytes, chloroquine pressure, and the relative parasite survival advantage of resistant strains of falciparum malaria in West Africa. Amer J Trop Med Hyg 55: 350-351.
17. Wang P, Brooks DR, Sims PFG, Hyde JE 1995. A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum. Mol Biochem Parasitol 71: 115-125.
18. Wang P, Lee CS, Bayoumi R, Djimde A, Doumbo O, Swedberg G, Dao LD, Mshinda H, Tanner M, Watkins WM, Sims PFG, Hyde JE 1997. Resistance to antifolates in Plasmodium falciparium monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. Mol Biochem Parasitol 89: 161-177.
19. Watkins WM, Mberu EK, Winstanley PA, Plowe CV 1997. The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses. Parasitol Today 13: 459-464.
20. Wellems TE, Panton LJ, Gluzman IY, do Rosario VE, Gwadz RW, Walker-Jonah A, Krogstad DJ 1990. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature 345: 253-255.
21. Wernsdorfer WH, Payne D 1988. Drug sensitivity tests in malaria parasites, p. 1765-1794. In WH Wernsdorfer, I McGregor (eds), Malaria - Principles and Practice of Malariology, Churchill Livingstone, Edinbourg, London, Melbourn, New York.
22. Wernsdorfer WH 1991. The development and spread of drug-resistant malaria. Parasitol Today 11: 297-303.
23. WHO - World Health Organization 1990. Practical chemotherapy of malaria. Technical Report Series 805. WHO, Geneva.
24. WHO - World Health Organization 1993. Implementation of the global malaria control strategy. Report of a WHO Study Group on the implementation of the Global Plan of Action for Malaria Control 1993-2000. WHO, Geneva.
25. WHO - World Health Organization 1996. Assessment of therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. WHO/MAL/96. 1077.